Fresenius Medical Care Corporation (NYSE:FMS) saw a significant decrease in short interest during the month of July. As of July 31st, there was short interest totalling 389,571 shares, a decrease of 42.0% from the July 14th total of 672,083 shares. Based on an average daily volume of 172,583 shares, the days-to-cover ratio is currently 2.3 days.

Several research firms have recently commented on FMS. UBS AG reaffirmed a “sell” rating on shares of Fresenius Medical Care Corporation in a research report on Tuesday, July 4th. DZ Bank AG reaffirmed a “neutral” rating on shares of Fresenius Medical Care Corporation in a research report on Thursday, May 11th. Zacks Investment Research downgraded Fresenius Medical Care Corporation from a “strong-buy” rating to a “hold” rating in a research report on Wednesday. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $44.00 target price on shares of Fresenius Medical Care Corporation in a research report on Wednesday, July 5th. Finally, BidaskClub downgraded Fresenius Medical Care Corporation from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. One research analyst has rated the stock with a sell rating, five have issued a hold rating and seven have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $48.67.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Royal Bank of Canada raised its position in Fresenius Medical Care Corporation by 6.4% in the second quarter. Royal Bank of Canada now owns 501,694 shares of the company’s stock worth $24,248,000 after buying an additional 30,119 shares during the period. Goldman Sachs Group Inc. raised its position in Fresenius Medical Care Corporation by 12.1% in the second quarter. Goldman Sachs Group Inc. now owns 228,756 shares of the company’s stock worth $11,056,000 after buying an additional 24,705 shares during the period. YorkBridge Wealth Partners LLC raised its position in Fresenius Medical Care Corporation by 19.4% in the second quarter. YorkBridge Wealth Partners LLC now owns 4,613 shares of the company’s stock worth $222,000 after buying an additional 749 shares during the period. Stifel Financial Corp purchased a new position in Fresenius Medical Care Corporation during the second quarter worth approximately $225,000. Finally, OxFORD Asset Management LLP purchased a new position in Fresenius Medical Care Corporation during the second quarter worth approximately $2,460,000. Hedge funds and other institutional investors own 2.81% of the company’s stock.

Shares of Fresenius Medical Care Corporation (NYSE FMS) opened at 46.50 on Thursday. The company’s 50-day moving average price is $47.44 and its 200-day moving average price is $44.92. The firm has a market cap of $28.54 billion, a P/E ratio of 20.31 and a beta of 0.47. Fresenius Medical Care Corporation has a 12 month low of $38.05 and a 12 month high of $50.22.

Fresenius Medical Care Corporation (NYSE:FMS) last released its quarterly earnings results on Tuesday, August 1st. The company reported $0.48 EPS for the quarter, missing analysts’ consensus estimates of $0.53 by $0.05. The firm had revenue of $4.47 billion for the quarter, compared to analysts’ expectations of $5.20 billion. Fresenius Medical Care Corporation had a net margin of 7.06% and a return on equity of 11.57%. The firm’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same quarter last year, the firm earned $0.96 earnings per share. On average, analysts predict that Fresenius Medical Care Corporation will post $2.33 EPS for the current year.

TRADEMARK VIOLATION WARNING: “Short Interest in Fresenius Medical Care Corporation (FMS) Declines By 42.0%” was first published by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright legislation. The original version of this story can be accessed at https://www.americanbankingnews.com/2017/08/17/short-interest-in-fresenius-medical-care-corporation-fms-declines-by-42-0.html.

Fresenius Medical Care Corporation Company Profile

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.

Receive News & Ratings for Fresenius Medical Care Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care Corporation and related companies with MarketBeat.com's FREE daily email newsletter.